• Search History (Register)
  • MeSH Browser
  • [Clear]
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canada’s Drug Agency (CDA-AMC)
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Regione Emilia Romagna
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Canada
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply

Welcome to the international HTA database

CSV RIS
Showing [3358 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2013     Health Quality Ontario (HQO) Electrocardiograms for diagnosing ischemia as a precipitant to acute heart failure: a rapid review
2013     Health Quality Ontario (HQO) Relationship of patient volume and stroke outcomes: a rapid review
2013     Health Quality Ontario (HQO) Action plans for individuals with chronic obstructive pulmonary disease (COPD): a rapid review
2013     Health Quality Ontario (HQO) Inhospital physiotherapy for acute exacerbations of chronic obstructive pulmonary disease (AECOPD): a rapid review
2013     Health Quality Ontario (HQO) B-type natriuretic peptide testing: a rapid review
2013     Health Quality Ontario (HQO) Chest X-rays for diagnosing pulmonary infection as a precipitant of acute heart failure: a rapid review
2012     Institute for Clinical Evaluative Sciences (ICES) Health outcomes for better information and care (HOBIC): acute care in Ontario
2012     Institute for Clinical Evaluative Sciences (ICES) Ontario stroke evaluation report 2012: prescribing system solutions to improve stroke outcomes
2012     Institute for Clinical Evaluative Sciences (ICES) Hospital care for all: an equity report on differences in household income among patients at Toronto Central Local Health Integration Network (TC LHIN) hospitals, 2008-2010
2012     Institute for Clinical Evaluative Sciences (ICES) Seven more years: the impact of smoking, alcohol, diet, physical activity and stress on health and life expectancy in Ontario
2012     Institute for Clinical Evaluative Sciences (ICES) Regional measures of diabetes burden in Ontario
2012     Institute for Clinical Evaluative Sciences (ICES) Comparison of primary care models in Ontario by demographics, case mix and emergency department use, 2008/09 to 2009/10
2012     Institute for Clinical Evaluative Sciences (ICES) Payments to Ontario physicians from ministry of health and long-term care sources, 1992/93 to 2009/10
2012     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [Treatment of obesity in children and adolescents in primary and secondary care settings recommendations: clinical practice guidelines]
2012     Technology Assessment at SickKids (TASK) The use of biologic response modifiers in polyarticularcourse juvenile idiopathic arthritis - a systematic review update
2012     Institute for Clinical Evaluative Sciences (ICES) Opening eyes, opening minds: the Ontario burden of mental illness and addictions report
2012     Medical Advisory Secretariat (MAS) Specialized community-based care: an evidence-based analysis
2012     Institute of Health Economics (IHE) First and second trimester prenatal screening for trisomies 13, 18, and 21 and open neural tube defects
2012     Institute of Health Economics (IHE) Bariatric treatments for adult obesity
2012     Medical Advisory Secretariat (MAS) Genetic testing for predisposition to dilated cardiomyopathy
2012     Institute of Health Economics (IHE) Insulin pump therapy for type 1 diabetes
2012     Technology Assessment Unit of the McGill University Health Centre (MUHC) The clinical effectiveness and cost of a pneumococcal urine antigen immunochromatographic test (BinaxNOW Streptococcus pneumoniae) in the diagnosis of community acquire Streptococcus pneumoniae pneumonia in patients admitted to hospital
2012     Institut national d'excellence en sante et en services sociaux (INESSS) [Anti-angiogenic drugs in the treatment for age-related macular degeneration: issues associated with their use in Québec]
2012     Institut national d'excellence en sante et en services sociaux (INESSS) [Sentinel lymph node biopsy in breast cancer treatment: indications and contraindications]
2012     Institut national d'excellence en sante et en services sociaux (INESSS) [Overview of the use of antihypertensive agents by adults covered by the Québec public prescription drug insurance plan]
2012     Institut national d'excellence en sante et en services sociaux (INESSS) [Complications associated with the surgical instruments used in tonsillectomies]
2012     Institut national d'excellence en sante et en services sociaux (INESSS) [Description of the use of Proton Pump Inhibitors (PPIs) in adults covered by the public prescription drug insurance plan]
2012     Institut national d'excellence en sante et en services sociaux (INESSS) [Diagnosis and treatment of Chronic Cerebrospinal Venous Insufficiency (CCSVI) in people with Multiple Sclerosis (MS)]
2012     Institut national d'excellence en sante et en services sociaux (INESSS) [Organization and provision of rehabilitation services for stroke patients and their families: a review of the evidence]
2012     Institut national d'excellence en sante et en services sociaux (INESSS) [NOTICE – Transcatheter aortic valve implantation: Evaluation of the evidence and synthesis of organizational issues]
2012     Institut national d'excellence en sante et en services sociaux (INESSS) [Sentinel lymph node biopsy in breast cancer treatment: efficacy and safety]
2012     Institut national d'excellence en sante et en services sociaux (INESSS) [Study of antipsychotic use. Part 3 : Adults aged 25 or older, primarily those 65 or older diagnosed with dementia]
2012     Institut national d'excellence en sante et en services sociaux (INESSS) [Quality indicators for primary care professionals and managers]
2012     Institut national d'excellence en sante et en services sociaux (INESSS) [Immunochemical fecal occult blood. Determination of a positivity threshold for the upcoming demonstration projects under Québec's colorectal cancer screening program]
2012     Institut national d'excellence en sante et en services sociaux (INESSS) [Promising measures to reduce the use of avoidable obstetrical interventions with low-risk women]
2012     Institut national d'excellence en sante et en services sociaux (INESSS) [Evaluation of the evidence on the HeartMate II and HeartWare ventricular assist devices for the treatment of chronic end-stage heart failure]
2012     Institut national d'excellence en sante et en services sociaux (INESSS) [Specialized services for people with alzheimer's disease]
2012     Medical Advisory Secretariat (MAS) Internet-based device-assisted remote monitoring of cardiovascular implantable electronic devices
2012     Institut national d'excellence en sante et en services sociaux (INESSS) [Clinical guides in antibiotic treatment, 2nd series]
2012     Institut national d'excellence en sante et en services sociaux (INESSS) [Diagnosis and treatment of chronic cerebrospinal venous insufficiency (CCSVI) for people with multiple sclerosis]
2012     Institut national d'excellence en sante et en services sociaux (INESSS) [Budget impact analysis of increasing kidney transplantation in Québec]
2012     Institut national d'excellence en sante et en services sociaux (INESSS) [Implantable ventricular assist devices: assessment of evidence and required elements to establish a clinical registry in Québec]
2012     Institut national d'excellence en sante et en services sociaux (INESSS) [Low-intensity ultrasound for the treatment of fractures]
2012     Medical Advisory Secretariat (MAS) Internet-based device-assisted remote monitoring of cardiovascular implantable electronic devices: an evidence-based analysis
2012     Medical Advisory Secretariat (MAS) Chronic obstructive pulmonary disease (COPD) evidentiary framework
2012     Institut national d'excellence en sante et en services sociaux (INESSS) [Promising measures to reduce the use of a avoidable obstetrical interventions with low-risk women]
2012     Medical Advisory Secretariat (MAS) Influenza and pneumococcal vaccinations for patients with chronic obstructive pulmonary disease (COPD): an evidence-based review
2012     Medical Advisory Secretariat (MAS) Smoking cessation for patients with chronic obstructive pulmonary disease (COPD): an evidence-based analysis
2012     Institut national d'excellence en sante et en services sociaux (INESSS) [Sentinel lymph node biopsy in breast cancer treatment: efficacy and safety]
2012     Medical Advisory Secretariat (MAS) Community-based multidisciplinary care for patients with stable chronic obstructive pulmonary disease (COPD): an evidence-based analysis
2012     Medical Advisory Secretariat (MAS) Pulmonary rehabilitation for patients with chronic pulmonary disease (COPD): an evidence-based analysis
2012     Medical Advisory Secretariat (MAS) Long-term oxygen therapy for patients with chronic obstructive pulmonary disease (COPD): an evidence-based analysis
2012     Medical Advisory Secretariat (MAS) Noninvasive positive pressure ventilation for acute respiratory failure patients with chronic obstructive pulmonary disease (COPD): an evidence-based analysis
2012     Institut national d'excellence en sante et en services sociaux (INESSS) [Transcatheter aortic valve implantation: Evaluation of the evidence and synthesis of organizational issues]
2012     Medical Advisory Secretariat (MAS) Noninvasive positive pressure ventilation for chronic respiratory failure patients with stable chronic obstructive pulmonary disease (COPD): an evidence-based analysis
2012     Institut national d'excellence en sante et en services sociaux (INESSS) [Use of intrathecal pumps in chronic pain management: efficacy, safety, clinical indications and organizational methods]
2012     Medical Advisory Secretariat (MAS) Hospital-at-home programs for patients with acute exacerbations of chronic obstructive pulmonary disease (COPD): an evidence-based analysis
2012     Medical Advisory Secretariat (MAS) Home telehealth for patients with chronic obstructive pulmonary disease (COPD): an evidence-based analysis
2012     Technology Assessment Unit of the McGill University Health Centre (MUHC) Drotrecogin alfa (Activated) in severe sepsis: a systematic review of observational studies (Update of Report 29)
2012     Medical Advisory Secretariat (MAS) Cost-effectiveness of interventions for chronic obstructive pulmonary disease (COPD) using an Ontario policy model
2012     Technology Assessment Unit of the McGill University Health Centre (MUHC) Video capsule endoscopy for obscure GI bleeding and Crohn's disease (Update of Report 7)
2012     Medical Advisory Secretariat (MAS) Experiences of living and dying with COPD: a systematic review and synthesis of the qualitative empirical literature
2012     Technology Assessment Unit of the McGill University Health Centre (MUHC) 532 nm KTP laser for vocal fold surgery
2012     Medical Advisory Secretariat (MAS) Transcatheter aortic valve implantation (TAVI) for treatment of aortic valve stenosis: an evidence-based analysis (Part B)
2012     Technology Assessment Unit of the McGill University Health Centre (MUHC) Use of serum procalcitonin levels in treatment decisions for adult patients in the intensive care unit
2012     Medical Advisory Secretariat (MAS) Twenty-four-hour ambulatory blood pressure monitoring in hypertension: an evidence-based analysis
2012     Technology Assessment Unit of the McGill University Health Centre (MUHC) The impact of reports of The Technology Assessment Unit of the McGill University Health Centre
2012     Medical Advisory Secretariat (MAS) Multiple intravenous infusions. Phase 1b: practice and training scan
2012     Technology Assessment Unit of the McGill University Health Centre (MUHC) Hyaluronic acid fat graft myringoplasty or Epidisk Tympanoplasty (ET)
2012     Medical Advisory Secretariat (MAS) Epilepsy surgery: an evidence summary
2012     Medical Advisory Secretariat (MAS) Epilepsy care in Ontario: an economic analysis of increasing access to epilepsy surgery
2012     Medical Advisory Secretariat (MAS) Metal-on-metal hip resurfacing arthroplasty: an analysis of safety and revision rates
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Non-invasive bi-level positive airway pressure as a weaning respiratory intervention for adult patients who have received pre-hospital continuous positive airway pressure to manage acute conditions: a review of the clinical evidence and guidelines
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Fall prevention in adults with mental health and substance use needs: a review of the clinical evidence and guidelines
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Sterilization equipment and requirements for endoscopy equipment: a review of the clinical evidence and guidelines
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Standard equipment for the usual care of bariatric patients: a review of the clinical evidence and guidelines
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Prevention strategies for substance misuse: a review of the clinical evidence
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Mindfulness training for weight loss in obese adults: a review of the clinical evidence and guidelines
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Dexmedetomidine for adult patients undergoing surgery: a review of clinical efficacy and safety
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Topical oxygen treatment for wound healing: a review of clinical and cost-effectiveness
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Assessment of high sensitivity cardiac troponin T assay for the rapid diagnosis of acute coronary syndrome and acute myocardial infarction in the emergency room: a review of the clinical and economic evidence
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Influenza vaccination for prevention of cross-species infection: a review of the clinical evidence
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Removable rigid dressings for leg amputation: a review of the clinical effectiveness, cost effectiveness and guidelines
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Retreatment, switching and extended therapy with boceprevir and telaprevir for chronic hepatitis C infection: a review of the clinical effectiveness and safety
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Treatment of anemia and neutropenia in patients with chronic hepatitis C infection treated with peginterferon-ribavirin based regimens with or without protease inhibitors: a review of the clinical evidence
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Protease inhibitor use for chronic hepatitis C infection in special populations: a review of the clinical evidence and guidelines
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Newborn screening for krabbe leukodystrophy: a review of the clinical and cost effectiveness and guidelines
2012     HTA Unit, University of Calgary Corneal crosslinking for keratoconus and corneal crosslinking for other corneal thinning disorders
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Smoking cessation interventions for pregnant women and mothers of infants: a review of the clinical effectiveness, safety, and guidelines
2012     HTA Unit, University of Calgary Radiofrequency ablation for low back pain
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Campus of care models for adults with disabilities and seniors: a review of clinical benefits and harms and cost-effectiveness
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Lipid lowering agents for stroke prevention: a review of the clinical evidence, safety and guidelines
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Dabigatran for stroke prevention in atrial fibrillation: a review of the evidence on safety
2012     Institute of Health Economics (IHE) The effectiveness and safety of preschool hearing screening programs
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Triptans for migraine headaches: a review of clinical evidence on safety
2012     Institute of Health Economics (IHE) The safety and effectiveness of preschool vision screening
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Olopatadine for the treatment of allergic conjunctivitis: a review of the clinical efficacy, safety, and cost-effectiveness
2012     Institute of Health Economics (IHE) The safety and efficacy/effectiveness of using automated testing devices for universal newborn hearing screening: an update
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Diagnosis and treatment of pineal gland cysts: a review of the clinical effectiveness and guidelines
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Congestive heart failure follow-up models: a review of the clinical effectiveness